Advertisement
Screener

X4 PHARMACEUTICALS, INC (XFOR) Auditor

X4 PHARMACEUTICALS, INC Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-17: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts, US.
  • 2025-03-26: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts, US.
  • 2024-03-21: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts, US.
  • 2023-03-21: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts, US.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-172025-12-31PricewaterhouseCoopers LLP238Boston, Massachusetts, US
2025-03-262024-12-31PricewaterhouseCoopers LLP238Boston, Massachusetts, USNo
2024-03-212023-12-31PricewaterhouseCoopers LLP238Boston, Massachusetts, USNo
2023-03-212022-12-31PricewaterhouseCoopers LLP238Boston, Massachusetts, USNo
2022-03-172021-12-31PricewaterhouseCoopers LLP238Boston, Massachusetts, USNo
2021-03-192020-12-31PricewaterhouseCoopers LLPBoston, MassachusettsNo
2020-03-122019-12-31PricewaterhouseCoopers LLPBoston, Massachusetts
2019-03-112018-12-31PricewaterhouseCoopers LLPBoston, MA
2018-03-092017-12-31PricewaterhouseCoopers LLPBoston, MA

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34